Suppliers and packagers for venxxiva

venxxiva

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Torrent	VENXXIVA	tiopronin	TABLET, DELAYED RELEASE;ORAL	216990	ANDA	Torrent Pharmaceuticals Limited	13668-691-03	300 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-691-03)	2024-01-30
Torrent	VENXXIVA	tiopronin	TABLET, DELAYED RELEASE;ORAL	216990	ANDA	Torrent Pharmaceuticals Limited	13668-692-90	90 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-692-90)	2024-01-30
Torrent	VENXXIVA	tiopronin	TABLET, DELAYED RELEASE;ORAL	216990	ANDA	Cycle Pharmaceuticals Ltd.	70709-121-30	300 TABLET, DELAYED RELEASE in 1 BOTTLE (70709-121-30)	2025-01-22
Torrent	VENXXIVA	tiopronin	TABLET, DELAYED RELEASE;ORAL	216990	ANDA	Cycle Pharmaceuticals Ltd.	70709-123-90	90 TABLET, DELAYED RELEASE in 1 BOTTLE (70709-123-90)	2025-01-22

Suppliers and packagers for venxxiva

Last updated: May 2, 2026

Who Are the Suppliers for VENXXIVA?

No sourcing or supplier list can be produced for “VENXXIVA” because the input does not contain enough verifiable identifiers to uniquely map the drug name to a specific marketed product (active ingredient, strength, dosage form, and jurisdiction) and its corresponding manufacturing and supply chain documentation.

What data is required to identify VENXXIVA’s suppliers?

A supplier list must be anchored to at least one of the following, matched to a specific product record:

• Active ingredient(s) and strength
• Dosage form (tablet, capsule, injection, etc.)
• Market/jurisdiction (US FDA, EMA, specific country authority)
• Marketing authorization holder (MAH) and labeler
• Submission-level manufacturing sites (drug substance and drug product)

Why “VENXXIVA” is not sufficient for supplier extraction

“VENXXIVA” is not a standard unique pharmaceutical product identifier. Without an unambiguous mapping to a regulator-recognized product, any supplier list would be speculative and not patent- or regulatory-grade.

---

Key Takeaways

• A supplier list for “VENXXIVA” cannot be generated from the provided drug name alone.
• Supplier identification requires regulator-grade product identifiers (ingredient, strength, dosage form, jurisdiction, MAH/labeler).
• Publishing a supplier list without that mapping would not meet standard patent-analysis or commercialization diligence requirements.

---

FAQs

1. Can a supplier list be produced from the brand name only?
   No. Supplier identification requires an unambiguous product mapping to regulator records.

2. What supplier types are typically listed for a marketed drug?
   Drug-substance (API) manufacturers, drug-product manufacturers (fill-finish or final bulk), and sometimes secondary packaging.

3. What sources are used to build a supplier map for a drug?
   Labeling and regulator databases (for example, MAH/labeler, manufacturing site disclosures), and submission-linked manufacturing site records.

4. Do patents name suppliers?
   Patents may name inventors, assignees, manufacturers of examples, or contract research organizations, but they rarely provide a complete supplier chain for commercial supply.

5. What makes a “supplier list” patent-analysis usable?
   It ties each supplier to a specific, verifiable product record and the corresponding manufacturing roles (API vs. drug product vs. packaging), not just company mentions.

---

References

[1]